| Trade Names: | |
| Synonyms: | |
| Status: | Approved (1974) |
| Entry Type: | Small molecule |
| Molecule Category: | Salt |
| UNII: | 7L3E358N9L |
| Parent Compound: | DOPAMINE |
Structure
| InChI Key | CTENFNNZBMHDDG-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
Physicochemical Descriptors
| Property Name | Value |
|---|---|
| Molecular Formula | C8H12ClNO2 |
| Molecular Weight | 189.64 |
| AlogP | 0.6 |
| Hydrogen Bond Acceptor | 3.0 |
| Hydrogen Bond Donor | 3.0 |
| Number of Rotational Bond | 2.0 |
| Polar Surface Area | 66.48 |
| Molecular species | BASE |
| Aromatic Rings | 1.0 |
| Heavy Atoms | 11.0 |
Pharmacology
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Membrane receptor
Family A G protein-coupled receptor
Small molecule receptor (family A GPCR)
Monoamine receptor
Dopamine receptor
|
1 | 1000-100000 | - | 2-11600 | - | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 67 |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Parkinson Disease | 3 | D010300 | ClinicalTrials |
Related Entries
Adverse Reactions
System Organ Classification (SOC)
Cross References
| Resources | Reference |
|---|---|
| ChEBI | 4698 |
| ChEMBL | CHEMBL1557 |
| EPA CompTox | DTXSID7020550 |
| FDA SRS | 7L3E358N9L |
| Guide to Pharmacology | 940 |
| KEGG | C03758 |
| PDB | LDP |
| PubChem | 65340 |
| SureChEMBL | SCHEMBL40951 |
| ZINC | ZINC00033882 |
CONTENTS